Company's senior V.P. of R&D describes a 'truly rewarding' product development process.
Cleared to market medical devices in 33 European countries.
Report analyzes 82,841 hip arthroplasties and 128,880 knee arthroplasties from 2012-2014.
LifeScience Alley chief tapped to lead organization.
CEO outlines plan for a ‘more lean and mean, cost competitive’ company.
Recently achieved milestones position the orthopedic sensor technology company for continued expansion.
CEO chats with ODT to discuss the group’s structure as well as current and future plans.
A contract manufacturer shares lessons from working with an automation firm to boost efficiency, reduce costs and keep jobs.
Medical device firms want regulatory and quality candidates with good writing skills.
AdvaMed leadership discusses states' efforts to alleviate the tax's pressure and details findings from the group's latest report.
Powered exoskeletons reclassified from class I to class II.
Sign up now to receive the free weekly newsletter, and more!